Karyopharm signals $130M–$150M revenue target for 2026 with pivotal myelofibrosis data readout ahead (NASDAQ:KPTI) Finances February 13, 2026 Comply with us on Google for the most recent inventory informationComply with Looking for Alpha on Google for the most…
